VILDAGARD OD 100MG (Vildagliptin (100mg))

Vildagard OD 100mg Tablet is a medication indicated for the management of type 2 diabetes mellitus. This treatment should be utilized alongside a balanced diet and consistent physical activity to effectively regulate blood glucose levels, helping to avert significant diabetes-related complications such as renal impairment and vision loss. Typically, Vildagard OD 100mg is recommended when lifestyle modifications and other treatments are insufficient to achieve desired glycemic control. It can be administered as a standalone therapy or in conjunction with other antidiabetic medications. Patients can take the tablet with or without food, and the prescribed dosage will be tailored to individual health conditions and blood glucose readings. It is essential to adhere to the prescribed regimen provided by your healthcare professional. Consistent daily intake at the same time helps maximize the medication’s efficacy. Discontinuing the medication should only occur following a doctor’s advice. Maintaining the recommended dietary and exercise plan is crucial for effective diabetes management, as lifestyle choices significantly influence blood sugar control. Common adverse reactions associated with Vildagard OD 100mg include low blood sugar (hypoglycemia), shaking, headaches, dizziness, tiredness, and feelings of nausea. It is vital to identify hypoglycemia symptoms such as feeling faint, excessive sweating, dizziness, and dry mouth, and to have quick-acting sugar sources available for relief. If side effects persist or cause concern, please consult your physician. Prior to commencing this medication, inform your healthcare provider of any history of renal issues, cardiac conditions, or pancreatic disorders. Pregnant or nursing individuals should also seek medical advice before initiation. Be aware that certain medications may interact with Vildagard OD 100mg, so it is important to disclose all current prescriptions to your doctor. Additionally, limit alcohol consumption as it may elevate the risk of low blood sugar occurrences. Regular monitoring of renal function and blood glucose is advisable to ensure therapeutic effectiveness.